Abstract
Background Stunting is a condition in which a child does not reach their full growth potential due to chronic undernutrition. It arises during the first two years of a child’s life and is associated with developmental deficiencies and life-long health problems. Current interventions provide some benefit, but new approaches to prevention and treatment grounded in a molecular understanding of stunting are needed. Epigenetic analyses are critical as they can provide insight into how signals from a poor environment lead to changes in cell function.
Results Here we profiled histone H3 acetylation on lysine 27 (H3K27ac) in peripheral blood mononuclear cells (PBMCs) of 18-week-old and one-year-old children living in an urban slum in Dhaka, Bangladesh. We show that 18-week-old children destined to become stunted have elevated levels of H3K27ac overall, functional analysis of which indicates activation of the immune system and stress response pathways as a primary response to a poor environment with high pathogen load. Conversely, overt stunting at 1-year-of age is associated with globally reduced H3K27ac that is indicative of metabolic rewiring and downregulation of the immune system and DNA repair pathways that are likely secondary responses to chronic exposure to a poor environment with limited nutrients. The results from one-year-old children also point toward deficiency in one-carbon metabolism, which is further supported by integrative analysis with results from histone H3 trimethylation on lysine 4 (H3K4me3).
Conclusions The epigenomes of stunted children undergo two global changes in H3K27ac within their first year of life, which are associated with probable initial hyperactive immune responses followed by reduced metabolic capacity. Limitation of one-carbon metabolites may play a key role in the development of stunting. Trial registration: ClinicalTrials.gov NCT01375647. Registered 17 June 2011, retrospectively registered.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT01375647 retrospective registration 3 week administrative delay
Funding Statement
This work was funded by the Bill and Melinda Gates Foundation (grant OPP1017093 to W.A.P) and National Institutes of Health (grant R01 AI043596 to W.A.P).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Ethical Review Board of icddr,b (FWA 00001468) and the Institutional Review Boards of the University of Virginia (FWA 00006183) and the University of Vermont (FWA 00000727). All samples were analyzed in a de-identified fashion. Informed consent was obtained for all participants (trial registration: ClinicalTrials.gov NCT01375647).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The datasets supporting the conclusions of this article are available in dbGaP repository, phs001073.v2.p1, https://www.ncbi.nlm.nih.gov/gap/. DbGaP identifiers are listed in Additional file 1: Table S1. Important scripts associated with this manuscript are available from: https://github.com/AubleLab/H3K27ac_in_stunting: (DOI: https://zenodo.org/badge/latestdoi/339230344).
https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001073.v2.p1
Abbreviations
- ChIP-seq
- chromatin immunoprecipitation followed by sequencing
- CVD
- cardiovascular diseases.
- FDR
- false discovery rate
- H2AK119
- histone H2A mono-ubiquitination on lysine 119
- H3K4me2
- histone H3 dimethylation on lysine 4
- H3K4me3
- histone H3 trimethylation on lysine 4
- H3K27ac
- histone H3 acetylation on lysine 27
- H3K27me3
- histone H3 trimethylation on lysine 27
- HAZ
- height-for-age z-score
- ΔHAZ (18 wk)
- difference in height-for-age z-scores between birth and 18 weeks of age
- ΔHAZ (1 yr)
- difference in height-for-age z-scores between birth and 1 year of age
- JMJD1C
- Jumonji domain containing 1C
- LDHA
- lactate dehydrogenase A
- LRP1
- LDL receptor related protein 1
- PBMC
- peripheral blood mononuclear cells
- PCA
- principal component analysis
- PPP
- pentose phosphate pathway
- PROVIDE
- performance of rotavirus and oral polio vaccines in developing countries
- SAM
- S-adenosyl methionine
- SSP
- serine synthesis pathway
- T2D
- type 2 diabetes
- TC-NER
- transcription coupled nucleotide excision repair
- TSS
- transcription start site
- WHO
- World Health Organization